Oncology: Phase III Trials

Course Description

This interactive and informative course provides a comprehensive overview of the planning and implementation of phase III and phase IV oncology clinical trials. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas.

In addition, delegates will benefit from the perspective and experience of the regulatory bodies on EU oncology directives.Case studies, worked examples and discussion sessions are inherent throughout this two-day course, encouraging a lively and positive learning environment.

CPD accreditation:
Healthcare's programmes are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation.

Topics to be covered include:

• Introduction to oncology clinical trial design and planning
• Informed consent/patient information
• EU oncology directives
• How trials impact on clinical practice
• Statistical analysis and reporting
• Health economics assessment
• Meta-analysis
• Quality of life assessment